IL2 and neoplasm: The third column, encompassed terms commonly associated with direct activation and enhancement of antitumor immune responses by cytokines, such as Stimulates anti-tumor immunity (antitumor immunity, immunotherapy, induction); Activating immune cells (activated killer cells, CD8+ T cells, dendritic cells, lymphocytes); Cytokines and cancer vaccines (cancer vaccine, cytokine, GM-CSF, interleukin-2, peptide); Clinical trial (in vitro, in vivo, phase I/II trial).